Screener
Evolent Health, Inc. EVH Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Evolent Health, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Evolent Health, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:53 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628908-26-000086
| Line item | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|
| Deferred revenue | 5 | (174) |
| Reserve for claims and performance-based arrangements | 186,202 | (131,454) |
| Other long-term liabilities | 80 | 803 |
| Net cash and restricted cash used in operating activities | (10,296) | (25,769) |
| Cash Flows Used In Investing Activities | ||
| Cash paid for asset acquisitions and business combinations | — | (56,047) |
| Return of equity method investments | 150 | 788 |
| Purchases of investments and contributions to equity method investees | — | (1,000) |
Item 1. Financial Statements
FAQ
- What is Evolent Health, Inc.'s operating cash flow?
- Evolent Health, Inc. (EVH) reported operating cash flow of -$9.31M in Q2 2026.
- How has Evolent Health, Inc.'s operating cash flow changed year-over-year?
- Evolent Health, Inc.'s operating cash flow increased by 69.3% year-over-year, from -$30.33M to -$9.31M.
- What is the long-term trend for Evolent Health, Inc.'s operating cash flow?
- Over 2 years (2021 to 2025), Evolent Health, Inc.'s operating cash flow has grown at a 0.1% compound annual growth rate (CAGR), from $38.75M to $38.84M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Evolent Health, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude